• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度至中度慢性肾衰竭中的心房利钠因子

Atrial natriuretic factor in mild to moderate chronic renal failure.

作者信息

Suda S, Weidmann P, Saxenhofer H, Cottier C, Shaw S G, Ferrier C

机构信息

Medizinische Poliklinik, University of Berne, Switzerland.

出版信息

Hypertension. 1988 May;11(5):483-90. doi: 10.1161/01.hyp.11.5.483.

DOI:10.1161/01.hyp.11.5.483
PMID:2966770
Abstract

The relationship between kidney function and plasma immunoreactive atrial natriuretic factor (irANF) levels as well as the effects of synthetic human ANF-(99-126) were investigated in 13 patients with mild to moderate chronic renal failure. Under basal conditions, glomerular filtration rate averaged 39 +/- 5 (SEM) ml/min/1.73 m2 and blood pressure (BP) averaged 166/107 +/- 7/2 mm Hg; 12 patients were hypertensive. Plasma irANF levels were significantly increased (98 +/- 16 vs 42 +/- 4 pg/ml in healthy control subjects; p less than 0.001) and correlated (p less than 0.05-0.005) inversely with hematocrit (r = -0.65) and positively with systolic BP (r = 0.75) or fractional sodium excretion (r = 0.75). Human ANF-(99-126) infusion for 45 minutes at 0.034 microgram/kg/min augmented (p less than 0.05-0.01) diuresis and urinary sodium, chloride, calcium, phosphate, and magnesium excretion. During the subsequent 45 minutes of human ANF-(99-126) infusion at a rate of 0.077 microgram/kg/min, diuresis and electrolyte excretion remained elevated (p less than 0.05-0.01). Glomerular filtration rate and effective renal plasma flow were not significantly modified, but filtration fraction rose progressively (p less than 0.01). Human ANF-(99-126) infusion decreased BP (p less than 0.05-0.01), produced hemoconcentration (hematocrit + 7%; p less than 0.01) without negative body fluid balance, and increased (p less than 0.01-0.001) plasma norepinephrine, insulin, and serum free fatty acids; plasma aldosterone and renin activity were unaltered during but rose after cessation of human ANF-(99-126) infusion.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对13例轻至中度慢性肾衰竭患者的肾功能与血浆免疫反应性心钠素(irANF)水平之间的关系以及合成人ANF-(99 - 126)的作用进行了研究。在基础状态下,肾小球滤过率平均为39±5(标准误)ml/min/1.73 m²,血压(BP)平均为166/107±7/2 mmHg;12例患者患有高血压。血浆irANF水平显著升高(健康对照者为42±4 pg/ml,而患者为98±16 pg/ml;p<0.001),并且与血细胞比容呈负相关(r = -0.65;p<0.05 - 0.005),与收缩压呈正相关(r = 0.75)或与钠排泄分数呈正相关(r = 0.75)。以0.034微克/千克/分钟的速率输注人ANF-(99 - 126) 45分钟可增加(p<0.05 - 0.01)尿量以及尿钠、氯、钙、磷和镁的排泄。在随后以0.077微克/千克/分钟的速率输注人ANF-(99 - 126)的45分钟内,尿量和电解质排泄仍保持升高(p<0.05 - 0.01)。肾小球滤过率和有效肾血浆流量无显著改变,但滤过分数逐渐升高(p<0.01)。输注人ANF-(99 - 126)可降低血压(p<0.05 - 0.01),导致血液浓缩(血细胞比容增加7%;p<0.01)且无体液负平衡,并增加(p<0.01 - 0.001)血浆去甲肾上腺素、胰岛素和血清游离脂肪酸;输注人ANF-(99 - 126)期间血浆醛固酮和肾素活性未改变,但在输注停止后升高。(摘要截取自250字)

相似文献

1
Atrial natriuretic factor in mild to moderate chronic renal failure.轻度至中度慢性肾衰竭中的心房利钠因子
Hypertension. 1988 May;11(5):483-90. doi: 10.1161/01.hyp.11.5.483.
2
Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
Am J Nephrol. 1989;9(4):291-9. doi: 10.1159/000167983.
3
Atrial natriuretic factor-specific antibody as a tool for physiological studies. Evidence for role of atrial natriuretic factor in aldosterone and renal electrolyte regulation.心房利钠因子特异性抗体作为生理学研究工具。关于心房利钠因子在醛固酮和肾脏电解质调节中作用的证据。
Circ Res. 1989 Nov;65(5):1324-9. doi: 10.1161/01.res.65.5.1324.
4
Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.正常受试者和心力衰竭患者的心房利钠因子。血浆水平以及对肽输注的肾脏、激素和血流动力学反应。
J Clin Invest. 1986 Nov;78(5):1362-74. doi: 10.1172/JCI112723.
5
Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.耳尿钠素(心房利钠因子)对犬血压、肾功能及肾素-醛固酮系统的影响。
Am J Med. 1984 Dec;77(6):1069-75. doi: 10.1016/0002-9343(84)90190-6.
6
Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
J Cardiovasc Pharmacol. 1992 May;19(5):691-700.
7
Effects of ANF infusion on the renal responses to lower-body negative pressure in humans.心房钠尿肽输注对人体肾脏对下体负压反应的影响。
J Cardiovasc Pharmacol. 1998 May;31(5):669-76. doi: 10.1097/00005344-199805000-00004.
8
Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.原发性高血压中肾小管对心房利钠因子的敏感性
J Hypertens. 1994 Apr;12(4):439-47.
9
Blood levels and renal effects of atrial natriuretic peptide in normal man.正常人体内心房利钠肽的血药浓度及肾脏效应
J Clin Invest. 1986 Mar;77(3):734-42. doi: 10.1172/JCI112368.
10
Long-term hypotensive and renal effects of atrial natriuretic peptide.心房利钠肽的长期降压及肾脏效应
Hypertension. 1986 Jun;8(6 Pt 2):II112-6. doi: 10.1161/01.hyp.8.6_pt_2.ii112.

引用本文的文献

1
[Atrial natriuretic peptide and its significance for arterial hypertension].[心房利钠肽及其在动脉高血压中的意义]
Klin Wochenschr. 1989 Nov 3;67(21):1069-76. doi: 10.1007/BF01741781.
2
Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure.心房利钠肽对慢性肾衰竭患者全身和肾脏血流动力学及肾脏排泄功能的影响。
Klin Wochenschr. 1991 Nov 26;69(19):895-903. doi: 10.1007/BF01649565.